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osting by EAbstract Mutations in the Autoimmune Regulator (AIRE) gene are responsible for Autoimmune
Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED). Within the thymic medulla,
AIRE regulates the expression of a large number of tissue-speciﬁc self-antigens (TSAs) and the rec-
ognisation of these TSAs by auto-reactive T-cells is a prerequisite step for thymic negative selection.
APECED patients will therefore develop multi-organ autoimmune disease because of the defective
role of AIRE in thymic negative selection. Aire-deﬁcient mice also develop multi-organ autoim-
mune disease and in this review we will focus on how both animal and cellular models have been
used to dissect biochemical function of AIRE/Aire which is an essential step toward the understand-
ing disease pathogenesis.
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Autoimmune Polyendocrinopathy Candidiasis Ectodermal
Dystrophy (APECED) (also known as Autoimmune Polyglan-
dular syndrome 1 – APS1) is an autosomal syndrome, diag-
nosed by the occurrence of two components of the clinical
triad of chronic mucocutaneous candidiasis, hypoparathyroid-
ism and adrenal insufﬁciency (Addison’s disease) [1–3], and
was ﬁrst reported in 1946 [4]. A wide variety of secondary dis-
orders have been identiﬁed in APECED patients, but as these
manifest with lower incidences, they are not required for diag-
nosis of APECED. These other clinical diseases include a vari-
ety of autoimmune endocrinopathies, ectodermal dystrophies
and gastrointestinal diseases (Table 1), as well as Sjo¨gren’s syn-
drome and keratoconjunctivitis. APECED patients also have a
high incidence of squamous-cell carcinoma of the oral mucosa
[1,2,5–10].
Studies reporting in 1997 had identiﬁed mutations in the
Autoimmune Regulator (AIRE) gene as the causative factors
of APECED [11,12]. Since then, a wide variety of different
models systems have been used to investigate both human
AIRE and murine Aire, varying from Aire knockout mice,
developed as a systemic model to mimic APECED, to cell lines
expressing recombinant AIRE or Aire and derivative variants,
to in vitro methods using puriﬁed proteins. Over the course of
these studies, AIRE/Aire has been identiﬁed to play an impor-
tant role in negative selection in the thymus and the develop-
ment of central tolerance. Model systems to study AIRE/
Aire are therefore important, not only in the context of APE-
CED, but also as a single causative gene disease model that can
be used to discern key regulatory aspects of the central toler-
ance mechanism. Here, we review the models systems used to
study the regulation and biochemical function of AIRE and
Aire, what we have learned from these, and discuss the rele-
vant merits and limitations of each system.Table 1 Diseases associated with APECED that are not part of th
Type of disease Disease
Autoimmune endocrinopathies IDDM, thyroid disea
Ectodermal dystrophies Alopecia areata, vitil
Gastro-intestinal diseases Pernicious anaemia,1.1. Tissue and cellular distribution of AIRE/Aire
The knowledge of the tissues and cells displaying AIRE/Aire
expression (summarised in Table 2) can be particularly useful
when making decisions upon which model system to use for
further functional studies into AIRE/Aire. If using mice, these
decisions can include which tissues to investigate in the study,
or if using cell lines, whether to choose a cell line derived from
a tissue that expressed AIRE/Aire natively, or to use a cell line
identiﬁed to have some degree of AIRE/Aire expression.
Thymic expression of AIRE/Aire at both the RNA and pro-
tein level has been conﬁrmed in both human and mice and iden-
tiﬁed in several other tissues across many studies investigating
AIRE/Aire expression. However, it must be noted that the
majority of studies investigating AIRE/Aire expression used
mice, predominately the C57BL/6 strain, although Aire expres-
sion in the BALB/c, CD1, NIMR (Naval Medical Research
Institute), NOD (Non-Obese Diabetic) and TRAMP (TRans-
genic Adenocarcinoma of the Mouse Prostate) mice has been
explored. Additionally, approximately half of the studies inves-
tigating extra-thymic AIRE expression in humans only exam-
ined PBMCs (Peripheral Blood Mononuclear Cells).
The reported extra-thymic expression of AIRE/Aire has
proven to be much more contentious than that of thymic
expression, as there has been an element of disparity between
the different studies, with a recent review discussing these ex-
tra-thymic AIRE/Aire expression studies in more depth [13].
A major contributory factor to these differences between re-
ports is the sensitivity of the assay used to detect AIRE/Aire
expression. This is most clearly seen when certain studies using
whole tissue homogenates could not detect AIRE/Aire in cer-
tain tissues, yet techniques that were able to detect AIRE/Aire
at the cellular level, identiﬁed AIRE/Aire expression in speciﬁc
cell sub-types of these tissues, typically either epithelial cells or
cells of the myeloid lineage. Additionally, AIRE/Aire expres-e diagnostic triad [1,2,5–10].
ses, pituitary defects and hypergonadotrophic hypogonadism
igo, keratopathy, nail and dental enamel dystrophy
malabsorption, cholelithiasis, hepatitis and chronic atrophic gastritis
Table 2 Tissues and speciﬁc cell types testing positive for AIRE/Aire expression in a report.
Organ/tissue Cell types/regions showing Aire expression
RNA detected [14,36,41,65–82] Protein detected
[14,28,30,40,41,64,67,68,71,73,75,77,80,81,83,84]
Thymus Detected in tissue. Also reported in
medulla and as a scattered
distribution amongst epithelial cells
of the medulla (MECs); Dendritic
cells; high levels found in CD80int and
CD80hi MECs
Detected in tissue. Also reported in medulla and
MECs; occasional medullary and cortical non-
epithelial cells; (margins of) Hassal’s corpuscles.
Found in CD80hiMHC IIhi cells; ly51lowMHCIIhi cells;
Cld3,4+ cells; CD45 cells; CD4+CD8+ thymocytes
Spleen Detected in tissue. Also reported in
border of red and white pulp;
CD11c+ cells; Dendritic cells
Detected in T-cell areas, T-cells and B-cells of white
pulp; lymphocytes, some neutrophilic granulocytes
and macrophages of red pulp; MHC II+ cells
Lymph nodes Detected in tissue. Also reported in
medulla and paracortical region;
CD45+ cells; gp38CD31 cell; very
low levels found in gp38+CD31
ﬁbroblastic reticular cells,
gp38CD31+ blood endothelial cells
and gp38+CD31+ lymphatic
endothelial cells
Detected in medulla; also lymphocytes and some
reticular cells of medulla; T-cell areas; light zone and
some of dark zone of germinal centres; MHC II+
cellsa
Kidney Detected in tissue Detected in epithelial cells of tubules; podocytes of
glomerulus; transitional epithelium of bladder
Lung Detected in tissue Epithelial cells of large airways; alveolar macrophages
Liver Detected in adult tissue and in foetal
liver
Hepatocytes; Ku¨ppfer cells
Ovary, fallopian tubes and uterus Detected in ovary and granulosa cells Detected in ovary, also in epithelial cells of fallopian
tube; follicular cells; oocytes
Uterus – epithelial cells of mucosa and secretory
glands; myometrium smooth muscle
Testis and prostate Detected in testes Detected in testes, also reported in spermatocytes and
spermatids in seminiferous tubules; spermatogionia;
Sertoli cells. Epithelial cells of protaste, epididymis
and seminal vesicle
Brain/nervous system Detected in tissue Cerebral cortex; hippocampus; amygdale; thalamic
nuclei; spinal cord; dorsal root ganglia; cortex,
purkinje and granular neurones
Pituitary Anterior and intermediate lobes
Thyroid Detected at low levels in tissue Parafollicular cells; epithelial cells of follicles
Adrenal gland Detected (at low levels) in tissue Zona glomerulosa; medullar chromaﬃn cells
Pancreas Exocrine and endocrine cells
Bone marrow Detected in tissue Some large megacaryocytes; lymphoblasts; and
myeloblasts
Skeletal muscle Detected in tissue
Peripheral blood CD14+ Monocytes; Dendritic cells
(including monocyte derivied,
plasmacytoid and lymphoid); CD4+
T-cells (both CD25+ and CD25);
and (weakly) in B-cells
CD11c+ (Dendritic) cells; lymphocytes; monocytes;
polymorphonuclear leukocytes; CD4CD8 cells (B-
cells); and granulocytes
Heart Detected (at low levels) in tissue
Gut/Alimentary tract Detected (at low levels) in tissue. Also
found in gut associated lymphoid
tissues (GALT)
Detected in secretory glands (accini and secretory duct
secretory cells); Alimentary canal (Epithelial and
glandular cells); goblet cells; GALT of large & small
bowel and appendix
Appendix Low levels in homogenate
Skin and hair Bulb of hair follicles and outer root sheath
Cell lines Jurkat; ATN-1; OTC-4; TW-EBV-
LCL; MDK3; THP-1; HaCaT
MDK3; IL-2T; THP-1; HaCaT
a See Poliani et al. [68] for a comprehensive list of cell surface markers found on AIRE+ cells in lymph node.
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at the RNA level, with inadequate anti-AIRE/Aire antibodies
suggested as a likely reason for this [13].This knowledge of the tissues and cells displaying AIRE/
Aire expression (summarised in table 2) can be used to decide
upon which model system to use for further functional studies
110 T. Lovewell, R. Tazi-Ahniniinto AIRE/Aire, with certain cell lines also observed to express
AIRE/Aire to some degree.
1.2. Subcellular localisation of AIRE/Aire
Whilst the subcellular distribution of AIRE from immunohis-
tochemical analysis of tissue sections has also been reported
[14], the majority of studies investigating its subcellular locali-
sation have used transfected cell-lines expressing recombinant
variants of AIRE/Aire. These have included wild type
AIRE/Aire, variants containing reported APECED mutations,
and those with speciﬁc regions deleted in order to discern the
function of speciﬁc domains in subcellular localisation [14–22].
Despite recombinant copies of both human AIRE and mur-
ine Aire being artiﬁcially expressed in differing species and tis-
sue origins, consistent patterns of subcellular localisation was
observed. AIRE was predominantly found in the nucleus
where it was often described as a ‘‘speckled pattern’’ forming
distinct nuclear bodies/dots (NBs), although it can also be
found in the cytoplasm, where it has a more ﬁlamentous distri-
bution [14,16,18,20,21]. Cytoplasmic AIRE was found on ﬁ-
bres that stretched from the nuclear envelope to the plasma
membrane and co-localised with microtubules and with vimen-
tin, a component of intermediate ﬁlaments [14,18,20,21]. A
GFP-AIRE expression vector transfected into HeLa cells iden-
tiﬁed that whilst AIRE did form NBs, this was dependent on
cell cycle and NBs would form after cell division but disappear
before mitosis [16].
2. Studies using mouse models
2.1. Pathways affecting Aire expression
Mouse models have been used extensively in studies involving
Aire, with a variety of transgenic mice used to great effect to
trace the development of Aire expressing cells, particularly of
those in the thymus. Lta/ and Ltbr/ mice were found to
have a reduction in thymic Aire expression, suggesting the lym-
photoxin pathway regulated Aire expression [23]. It was subse-
quently determined that the lymphotoxin pathway appears to
be involved in the organisation and/or development of the thy-
mus, and that Aire expressing cells differentiate from a sub-set
of the cells regulated by this pathway. In a related study,
NFjB2 (Nuclear Factor j B2) was found to be an important
part of this development pathway, through the use of
NFjB2/ mice [24].
Studies involving RANK/ (Receptor Activator of Nucle-
ar Factor j B) and TRAF6/ (TNF Receptor Associated Fac-
tor 6) mice identiﬁed that RANK/RANKL (RANK Ligand)
regulates Aire expression amongst mTEC precursor cells dur-
ing development via TRAF6, and that RANK signalling is
important for maintenance and turnover of Aire+ mTECs in
adults [25–27]. It was also discerned using transgenic mice that
Aire+ thymic cells were typically derived from Claudin-3+,
Claudin-4+ (Cld3,4+) cells, with the minority of Cld3,4
Aire+ cells being of dendritic cell origin [28].
2.2. Aire knockout mice
Within a relatively short period after the identiﬁcation of
AIRE as the causative gene in APECED, Aire knockoutmouse strains were developed as model organisms for the
study of APECED. These have subsequently been used in
studies investigating the molecular function of Aire and the
pathways it is involved in.
The original Aire knockout mice were generated using the
C57BL/6 mouse strain, and observed to produce auto-antibod-
ies directed towards a variety of organs, as well as displaying
lymphocytic inﬁltration in a number of organs too [29,30].
Comparisons between Aire knockout mice generated on differ-
ent genetic backgrounds (C57BL/6, BALB/c, NOD) identiﬁed
that there was variation in the targets of autoimmune attack
between the different strains, indicating that the genetic back-
ground can modulate autoimmune symptoms [31]. These
knockout mice also identiﬁed that Aire regulated the promis-
cuous expression of tissue speciﬁc antigens (TSAs) in the thy-
mus, and that this function has a role in the negative selection
of thymocytes in the thymus. Whilst Aire typically up-regu-
lated gene expression, up to one third of the genes found to
be differentially expressed were down-regulated in Aire+/+
mice compared to the Aire/ mice [32–34].
The gene expression proﬁle of Aire knockout mice com-
pared against their reciprocal wild type mice have since been
used in a number of studies to elucidate the repertoire of Aire
regulated genes [29,32–39]. Studies investigating the targets of
Aire regulated gene expression in medullary thymic epithelial
cells (mTECs) identiﬁed that the differentially expressed genes
tended to co-localise into chromosomal clusters (of approx.
200kb in size), but did not indicate a particular chromosomal
preference for Aire [32]. The level of expression of Aire regu-
lated genes has been shown to vary between not only between
different mice of the same genetic strain, but has a similar de-
gree of variation between the mTECs taken from the two thy-
mic lobes of the same mouse. Nevertheless, comparisons made
between the repertoires of Aire regulated genes in the mTECs
generated from mice of different genetic backgrounds (C57BL/
6, BALB/c and NOD) [34], showed elements of conservation
as well as divergence between the repertoires from these differ-
ent genetic backgrounds. Aire regulated gene expression has
also been compared between the mTECs and pancreatic islet
beta-cells of mice on the NOD genetic background, ﬁnding
quite a large divergence between the repertoires of differen-
tially expressed genes, although approx 1/3 of these genes were
down regulated as would be expected. Despite alternate meth-
ods used to determine these repertoires, wild type vs Aire/
for the mTECs and Rat Insulin Promoter driven expression
of recombinant Aire (RIP-Aire) vs wild type for pancreatic
beta cells, the level of divergence between these two repertoires
suggests that the repertoire of Aire regulated genes is strongly
inﬂuenced by tissue type [33].
The results from a number of studies using a range of trans-
genic mice that are either wild type (Aire+/+), heterozygote
knockout (Aire+/) or homozygote knockout (Aire/), have
suggested that Aire functions in a dose dependent fashion. Spe-
ciﬁc peripheral tissue antigens (Tff3, Ins2, Mup1, Spt1) were
found to be expressed at lower levels in Aire+/ mice than in
wild type mice, and at even lower levels in Aire/mice [40,41].
3. Studies using cell line models
Cell line models have mainly been used in two different ways in
the study of AIRE/Aire function. The ﬁrst is as a tool to ex-
Table 3 Summary of studies looking at speciﬁc proteins that interact with AIRE/Aire.
Protein Function Cell line used Findings
CBP (CREB Binding
Protein)
Transcription
co-factor
HEK293 AIRE binds to CBP via CH1 and CH3 domain on CBP
[42]. AIRE and CBP act synergistically to active IFNb
(interferon b) expression [35], and aﬀects expression of
other genes [59]
DAXX Role in
repression of
transcription
Cos-1 and HeLa N-terminal region of AIRE interacts with SPT domain of
DAXX in Cos-1 cells. DAXX suppressed AIRE mediated
activation of Insulin promoter, and suggestion that this is
via histone deacetylation [53]
DNA-PK
complex(DNA
Dependant Protein
Kinase)
Protein kinase THP-1 and HEK293 AIRE PHD1 domain interacted with Ku70, Ku80 and
DNA-PKcs in THP-1 cells. In HEK293 cells, full length
AIRE interacts with DNA-PKcs, and AIRE is
phosphorylated by the DNA-PK complex in the N-
terminus at residues T68 and S156 [46]
p63 Transcription
factor
HEK293 and P1.4
(human thymic epithelial
cells.)
SAND domain of AIRE interacts with TA domain of p63,
and is prevented by G228W-AIRE mutation. HLA class II
expression is reduced by p63 alone, but increased with co-
expression of p63 and AIRE [85]
PIAS-1(Protein
Inhibitor of Activated
STAT)
E3 SUMO
ligase
Cos-1 and Caco2
(human colon epithelial
cells)
CARD domain of AIRE interacts with c-terminal domain
of PIAS-1. AIRE and PIAS-1 activate expression from
Insulin promoter concurrently, whereas AIRE represses
CSTB (Cystatin B) promoter, which PIAS-1 activates.
AIRE does not undergo sumoylation [46]
pTEF-b(Positive
Transcription
Elongation Factor b)
Prepares
RNAPII for
transcription
elongation
HeLa-MAGI and 1C6
(mouse mTECs)
AIRE promotes transcription elongation. AIRE interacts
with cyclin T1 and cyclin dependent kinase 9 components of
P-TEFb complex, and recruits this complex to mouse Ins2
(Insulin 2) and Spt1 (salivary protein 1) promoters [54]
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tions of these speciﬁc recombinant proteins, typically in the
identiﬁcation of proteins that AIRE/Aire is able to bind to,
and the critical domains for this interaction. The second is as
a cellular model with which to discern either the factors that
affect AIRE/Aire expression, or the cellular effects of AIRE/
Aire.
3.1. Interaction of AIRE/Aire with other macro-molecules
One of the earliest complexes identiﬁed to be formed by AIRE/
Aire, was that of a homodimer and homotetramer, with this
ability ﬁrst determined using in vitro translated protein, and
veriﬁed using hybrid assays in yeast and mammalian cells
(HUH-7 and Cos-1) [42]. This oligomerisation was further cor-
roborated in later studies using recombinant protein expressed
in E. coli [43], and mammalian 2-hybrid assays using COS-1
cells [44].
In addition to its homo-multimerisation, AIRE has been
found not only to associate with the nuclear matrix during pro-
tein extractions [16,45,46], but also bind to DNA [43,47] and
Histone H3 [48–52]. Studies involving in vitro assays using
E. coli expressed recombinant protein, identiﬁed that whole
AIRE as well as certain domain deletion variants, bound to
DNA in a sequence speciﬁc manner via the SAND domain
and two PHD zinc ﬁnger domains [43,47].
In vitro assays were used to identify that the PHD-1 do-
main of AIRE bound to Histone H3, that this binding is inhib-
ited by methylation of the lysine4 residue of H3 (H3K4), and
also in the determination of the structure and interaction of
AIRE-PHD1 with a H3K4me0 peptide by NMR [49–51].
However, these ﬁndings lead to the exploration of recombinant
AIRE in HEK293 cells, ﬁnding that AIRE was typically local-ised in areas with low H3K4 methylation, and in ChIP assays,
that AIRE interacted with the promoters of the up-regulated
genes Insulin, Involucrin and S100A8, which ‘‘almost com-
pletely lacked H3K4me3’’, but showed less interaction, and
an enrichment of H3K4me3, for the promoters of the unaf-
fected genes S100A10 and GAPDH [49]. Co-expression of
PRMT6 (H3R2 methyltransferase) with AIRE in HEK293
cells was found to reduce AIRE mediated up-regulation of
Involucrin and S100A8. In addition, co-expression of the his-
tone demethylase, PLU-1, with Aire in the U2OS (a human
osteosarcoma) cell line, was found to increase the repertoire
of Aire regulated genes than with just Aire alone [48].
The studies exploring the interaction of AIRE/Aire with
other proteins, often used screening with yeast 2-hybrids
[46,53] or pull-down assays/co-immunoprecipitation [52,54,55]
to initially identify proteins that interactedwithAIRE/Aire (Ta-
ble 3). However, Pitka¨nen et al. selected CBP (CREB Binding
Protein) for a series of in vitro assays, as a potential co-factor
that interacted with AIRE as it was ‘‘the most common coacti-
vator’’ [42]. After a target protein/complex had been identiﬁed,
cell lines were typically then used either to corroborate in vitro
ﬁndings, or help discern particular protein domains involved
in the interaction, or to identify cellular effects of this interac-
tion. A broad screen of proteins co-immunoprecipitating with
recombinant Aire-FLAG fusion protein in HEK293 and 1C6
cells identiﬁed a range of proteins that interact with Aire, and
tested the effect of these identiﬁed proteins on recombinant Aire
mediated expression ofKRT14 (Keratin 14) in HEK293 cells by
knocking down their expression with shRNAs. The identiﬁed
proteins were grouped into four broad functional classes of
chromatin binding/structure, nuclear transport, pre-mRNA
processing and transcription, and Aire’s involvement in these
biochemical processes further tested. Aire was found to elevate
112 T. Lovewell, R. Tazi-Ahninithe levels of spliced (mature) mRNA, but not unspliced (pre-)
mRNA in HEK293 cells, and in the human 4D6 (thymic epithe-
lial) cell line, knockdown of the NPC-associated proteins
NUP93, XPO1, KNPB1 and RanBP2, caused cytosolic reten-
tion of Aire, suggesting an indirect effect on Aire mediated reg-
ulation of expression [52].
3.2. Regulation of AIRE/Aire expression
A number of studies have used cell lines to either identify
mechanisms that induce AIRE expression, or factors that are
involved in the regulation of AIRE expression.
Investigations by the Pa¨rt Peterson research group have
used COS-7 cells, HeLa cells, the THP-1 and U937 human
monocytoid cell lines and the TEC 1A3 human thymic cell line
to study the regulation of AIRE transcription. They deter-
mined the minimal AIRE promoter, consisting of the ﬁrst
350bp upstream of the ATG start codon (223bp upstream of
the transcription start site). Additionally, they identiﬁed and
validated transcription factor binding sites in this region for
Ets-1, AP-1, Sp-1 (GC box), NF-y (an inverted CCAAT
box) and a TATA box motif [56,57]. They also discerned that
regulation of AIRE expression is mediated by methylation of
the AIRE promoter, and were able to up-regulate AIRE
expression by treating cells with the DNA methyltransferase
inhibitor 5-aza-20-deoxycytidine, which was further increased
upon addition of trichostatin A, a histone deactylase inhibitor,
to the treatment regimen [56]. Nagafuchi et al. [58] were able to
induce AIRE expression in the OTC-4 myelomonocytic
leukaemia cell line for a limited time (less than 72 h from the
commencement of treatment) by treating the cells with granu-
lo-monocyte colony stimulating factor (GM-CSF), triggering
the cell line to differentiate from monoblast-like cells into
monocytes. They were able to determine that this expression
was mediated through the p38 MAPK pathway, through the
identiﬁcation of phosphorylated proteins in the treated cells,
and co-treatment with speciﬁc inhibitors alongside GM-CSF.
3.3. AIRE/Aire regulated gene expression
One of the earliest studies to identify targets of AIRE/Aire reg-
ulated gene expression in cell lines used ribonuclease protection
assays to determine differential expression of a limited selection
of cytokine and chemokine genes in the murine Raw 264.7 mac-
rophage cell line [59]. Comparisons were made between the
unmodiﬁed cell line and a variant carrying a stable transfectant
of a recombinant Aire expression vector. IL-1ra, whose expres-
sion is normally regulated in a CBP dependent manner, was one
of the few genes indentiﬁed to have a signiﬁcant change in
expression as a result of recombinant Aire expression. It was
hypothesised that Aire dependent down-regulation of expres-
sion of this, and other genes, might be mediated by Aire seques-
tering CBP and quenching its normal function.
A report into AIRE regulated gene expression in the U937
cell line was released shortly after this study was published,
and used a custom cDNA chip to investigate the effect of sta-
ble expression of recombinant AIRE on the cells transcriptome
[60]. Similar to ﬁndings in mice, AIRE was found to both up-
and down-regulate gene expression, with approx 1/3 of the
genes affected being down-regulated (48 genes up-regulated
and 24 down regulated). Later studies using HEK293 cells
found that recombinant AIRE up-regulated the expression ofInsulin, Involucrin and S100A8 by QPCR [49], and using Illu-
mina beadchip arrays, identiﬁed signiﬁcant up- and down-reg-
ulation of 140 and 154 genes respectively [61]. The genes
identiﬁed in the beadchip array were also found to be more
clustered than would be expected at random, and that AIRE
down-regulated genes often had high levels of initial expres-
sion, and up-regulated genes typically had low levels of initial
expression and lacked H3K4me3 and AcH3 markers on his-
tones near to their promoters. Recombinant Aire expression
in HEK293 cells was found to generate a 2-fold or greater
up-regulation of expression in 900 genes and similar down-
regulation of expression for 300 genes [52].4. Choice of model system
There are many good reasons why mice have been used so
extensively out of all the studies investigating AIRE/Aire func-
tion. Firstly, they provide a reproducible and modiﬁable model
system that can have cells which have prolonged native high
level expression of Aire. Secondly, they are the only genetically
manipulatable system which can be used in investigations into
the systemic effects of AIRE/Aire and its role in the develop-
ment of central tolerance and autoimmune pathogenesis.
Additionally, the variety of different genetic strains of mice en-
abled the identiﬁcation that genetic background had a signiﬁ-
cant effect on Aire function. However, this can be both a curse
and a beneﬁt. On one hand this could complicate the interpre-
tation of results, for example, whether certain downstream ef-
fects of Aire have been modulated due to the genetic
background. Whereas on the other hand, experiments using
a wide variety of different mouse strains could help identify
the full range of the downstream effects of Aire, and compar-
isons of related experiments using different strains of mice can
identify conserved Aire functionality.
A particular disadvantage using mice to determine the bio-
chemical targets and downstream pathways of Aire is that
there is likely to be increased heterogeneity between the cells
extracted and tested. Aire has been found to be expressed in
only speciﬁc cells of certain tissues, and thus there is the poten-
tial for non-relevant cells to modulate observed results. In
addition, intra-tissue variation has already been reported,
and thus this increased background noise may serve to reduce
the sensitivity to detect all Aire dependent effects. Finally,
whilst one must always be conscious of the potential for vari-
ation in a gene’s effects when using mice (or another organism)
and their corresponding gene homolog as a model for the
study of a human disorder and/or gene, particular consider-
ation must be taken for the study of AIRE and APECED.
There has been published debate over the relevance of Aire
knockout mice as an appropriate model for APECED [62–
64], particularly as these mice have not displayed the full range
of symptoms of APECED. However, as pointed out, genetic
background can modify disease symptoms observed in these
knockout mice, thus the lack of a wide range of genetically di-
verse Aire knockout mice, compared to the genetic diversity
amongst APECED patients, may in part explain this absence
of a full range of symptoms.
Cell line models can overcome some of the problems that
could affect mouse models, although they too have certain
drawbacks in their use as model systems. One of the major
beneﬁts of using cell lines, is that it is possible to test the bio-
Models to explore the molecular function and regulation of AIRE 113chemical interactions of human AIRE within a human cell
line, or those of murine Aire without the need of whole mice.
This is coupled with the fact that a single mouse will have a
limited number of Aire+ cells from a particular tissue, whereas
cell culture can generate many more AIRE+ or Aire+ cells,
and thus provide sufﬁcient cell numbers from a single source
for use in experiments, as has previously reported [52]. Addi-
tionally it may be possible to obtain cell lines that have been
derived from appropriate tissues, such as the thymus, which
as human tissue samples could be harder to resource. Unfortu-
nately, there is still a limitation to the range of the different
sub-populations that make up a tissue that are available as a
cell line. Thus, as AIRE/Aire is only expressed in certain cell
types within a speciﬁc tissue, there may need to be compromise
in the design of experiments, as to how similar the cell line of a
tissue is to the native cellular environment in the tissue where
AIRE/Aire is natively expressed. This is obviously less of an
issue if the study is focusing on the interaction between recom-
binant AIRE/Aire or modiﬁed variant with another recombi-
nant protein, rather than AIRE/Aire’s interaction with
macro-molecules native to the cellular.
In addition to this, due to different cell lines being derived
from different donor sources, when comparing results from
two different cell lines, there is likely to be an element of genet-
ic heterogeneity. These genetic differences could provide addi-
tional ‘‘background noise’’ that might modulate the observed
results, and thus may affect the sensitivity to determine effects
of the other differences between the cell lines, such as species or
tissue type the cell line was derived from.
One major advantage to cell lines is that they are relatively
simple to modify, whether to express recombinant proteins, or
to knockdown gene expression by RNAi, or to perform differ-
ent treatment regimens with various additives to growth med-
ia. Unfortunately, this is coupled with the drawback of the
relative dearth of cell lines that display native AIRE or Aire
expression. Whilst, AIRE expression has been induced in sev-
eral cell lines after treatment [56,58], the resultant cell lines
either expressed AIRE for only a relatively short period of
time [58], or the treatments to demethylate DNA and deacety-
late histones would have altered the cellular biochemistry to
make it an inadequate model for AIRE function [56]. Conse-
quently, many of the cell lines used to examine AIRE or Aire,
needed to introduce an artiﬁcial system to express recombinant
AIRE/Aire or another construct, such as a fusion protein, or
protein variants containing mutations or deletions or speciﬁc
domains, although there may be side-effects as a result of this.
For example, artiﬁcial expression of recombinant AIRE/Aire,
if driven by the CMV promoter (which is commonly used in
expression vectors) will generate higher levels of expression
than native AIRE/Aire expression, and thus the observed
functional effects may differ than what would be observed un-
der more native expression levels. However, this will be tem-
pered if different experimental variants are required, whether
using different variants of AIRE/Aire, or the expression of
additional recombinant proteins.
In short, all studies need to carefully decide whether the cel-
lular environment, whether murine or human tissue sample, or
tissue derivation of cell line, is appropriate for the focus of the
investigation. Mice can provide a model where the effects of
natively expressed Aire can be easily investigated, and can
identify Aire’s systemic effects on other cells and tissues, in
addition to the cellular environment. Whereas cell lines canbe used to model AIRE as well as Aire and provide larger
numbers of a more homogenous sample of cells in a system
that can be more easily modiﬁed, although the choice of cell
lines natively expressing AIRE or Aire is limited.
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